T2 adds coronavirus test to panels, per health network deal

By LabPulse.com staff writers

March 25, 2020 -- T2 Biosystems has signed a worldwide licensing agreement for a rapid test developed by New Jersey-based Hackensack Meridian Health for SARS-CoV-2.

Hackensack Meridian Health has been using its test on patients suspected of being infected with the virus under the U.S. Food and Drug Administration's emergency use authorization guidance.

Under terms of the pact, T2 Biosystems will adapt the novel coronavirus test to run on its T2Dx instrument, along with the company's T2Bacteria and T2Candida panels. By adding the SARS-CoV-2 test to its T2Dx platform, T2 Biosystems can assess patients suspected of primary or secondary infections associated with the virus. The results will help clinicians quarantine and treat patients and better allocate critical resources, according to the company.

Per the deal, the health network plans to adopt the T2Dx instrument and test panels within its Center for Discovery and Innovation. Hackensack Meridian Health includes 17 hospitals from Bergen to Ocean counties, a behavioral health hospital, and two rehabilitation hospitals. Additionally, the network has more than 500 patient care locations throughout the state, which include ambulatory care centers, surgery centers, home health services, and long-term care and assisted living communities.

T2 Biosystems advances new tests through BARDA funding
T2 Biosystems is accelerating the development of new direct-from-blood tests through a milestone-based funding contract with the U.S. Biomedical Advanced...
T2 Biosystems wins Medicare payment approval
T2 Biosystems said the U.S. Centers for Medicare and Medicaid Services has approved a new technology add-on payment for the firm's T2Bacteria panel sepsis...
T2 stretches out globally with sepsis assays
T2 Biosystems is introducing its T2Bacteria and T2Candida whole-blood panel diagnostics in five new countries -- Estonia, Greece, Ireland, Saudi Arabia,...
T2Bacteria panel proves itself, but will hospitals buy in?
The T2Bacteria panel was accurate and fast for detecting five common kinds of bacteria in the blood in a multicenter study published May 13 in the Annals...

Copyright © 2020 LabPulse.com

Last Updated np 3/25/2020 3:49:48 PM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current